All lobbying filings
ARENTFOX SCHIFF LLP
Lobbying for PHARVARIS, INC. · Late-stage biopharmaceutical company
Filing
Registration
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 15, 2025
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
Massachusetts
Lobbyists on this filing
6
-
KELSEY GRISWOLD-BERGER New on this filingPreviously held: Leg Asst, Sen. Burr (2021-2023); Leg Dir, Rep. C. Smith (2018-2021); Leg Dir, Rep. Pittenger (2018); Leg Dir, Rep. Blum (2017-2018); Leg Asst, Rep. Perry (2015-2017); Leg Asst (2014-2015), Leg Corr/Press Asst (2011-2014), Staff Asst (2011), Rep. Reed
-
OLIVER SPURGEON III New on this filingPreviously held: Legislative Correspondent, Rep. Hank Johnson (2009-2015); Staff Assistant, Rep. Hank Johnson (2007-2009)
-
PHILIP ENGLISH Former member of Congress New on this filingPreviously held: U.S. Representative (1995-2009)
-
STARSHINE CHUN New on this filingPreviously held: Executive Assistant/Deputy Scheduler, Sen. Brian Schatz (2021-2023)
-
DANIEL SJOSTEDT New on this filingPreviously held: Staff Assistant, Rep. Jeff Fortenberry (2016-2017)
-
LAURA EUGSTER DOYLE New on this filingPreviously held: Legislative Director, Rep. Philip English (1998-2002)
Lobbying activity
4
Advocacy of policies, legislation and regulation pertaining to pharmaceutical manufacturing, focusing on orphan drug production
Advocacy of policies, legislation and regulation pertaining to pharmaceutical manufacturing, focusing on orphan drug production
Advocacy of policies, legislation and regulation pertaining to pharmaceutical manufacturing, focusing on orphan drug production
Advocacy of policies, legislation and regulation pertaining to pharmaceutical manufacturing, focusing on orphan drug production
Foreign interests disclosed
2
-
PHARVARIS GMBHSwitzerland · Zug · owns 100% of the client · contributed $0.00
-
PHARVARIS N.V.Netherlands · Leiden · owns 100% of the client · contributed $0.00